Research Funding

Funding Opportunity Announcements

Browse below for Data Science Funding Opportunity Announcements.

This page last reviewed on September 14, 2018

Feed last updated: February 14 2019 11:48 am
Title FOA Number Organization Release Date Expiration Date Purpose Search Terms
U.S.-China Program for Biomedical Collaborative Research (R01 Clinical Trial Optional)



Jan 02 2019

Feb 22 2019

The purpose of the U.S.-China Program for Biomedical Collaborative Research is to stimulate collaborative basic, translational, and clinical research between United States (U.S.)-based researchers and Chinese researchers in the areas of cancer, environmental health, heart disease, blood disorders, diseases of the eye and visual system, mental health, and neurological disorders. Partnering U.S. and Chinese investigators must work jointly to submit identical applications to NIH and National Natural Science Foundation of China (NSFC), respectively. U.S. investigators must respond to the announcement from NIH, including the Chinese application as an attachment, and Chinese investigators must respond to a separate funding announcement from NSFC, including the NIH application as an attachment.

data science, computational, bioinformatics
The KUH Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed)



Jan 28 2019

Nov 21 2019

The purpose of the KUH/NIDDK Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) is to recruit exceptional graduate students who are recognized by their institutions for their high potential and to incentivize them to pursue a Kidney, Urologic or Hematologic (K, U, or H) postdoctoral position that ultimately positions them to become independent K, U, or H researchers. This two-phase award will facilitate completion of the doctoral dissertation and stablize the transition of highly talented Ph.D candidates from a variety of fields, including, but not limited to, engineering, statistics, data science, imaging, biochemistry and genetics into strong postdoctoral appointments that are focused on K, U or H research. It is anticipated that successful completion of this phased award will make the individual highly competitive for a subsequent NIDDK award (e.g., K99/R00, R01). Opportunities for career development activities relevant to their long-term career goals of becoming independent researchers will be provided. Graduate students who are already involved in K, U, or H research are encouraged to apply for the NIDDK F31 (PA-18-671).
This Funding Opportunity Announcement (FOA) does not allow applicants to propose to lead an independent clinical trial, but does allow applicants to propose research experience in a clinical trial led by a sponsor or co-sponsor

data science
The Application of Big Data Analytics to Drug Abuse Research (R01 Clinical Trial Optional)



Nov 01 2017

May 08 2019

The purpose of this FOA is to encourage the application of Big Data analytics to reveal deeper or novel insights into the biological and behavioral processes associated with substance abuse and addiction.NIDA recognizes that to accelerate progress toward understanding how the human brain and behavior is altered by chronic drug use and addiction, it is vital to develop more powerful analytical methods and visualization tools that can help capture the richness of data being generated from genetic, epigenetic, molecular, proteomic, metabolomic, brain-imaging, micro-electrode, behavioral, clinical, social, services, environmental studies as well as data generated from electronic health records.Applications for this FOA should develop and/or utilize computational approaches for analyzing large, complex datasets acquired from drug addiction research.The rapid increase of technologies to acquire unprecedented amounts of neurobiological and behavioral data, and an expanding capacity to store those data, results in great opportunity to bring to bear the power of the computational methods of Big Data analytics on drug abuse and addiction.

data science, big data, computational, bioinformatics, machine learning
Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)



Aug 01 2018

Apr 02 2019

This Funding Opportunity Announcement (FOA) invites eligible United States small business concerns (SBCs) to submit Small Business Technology Transfer (STTR) grant applications that propose to develop a product, process or service for commercialization with the aim of improving minority health and/or reducing health disparities in one or more NIH-defined health disparity population groups. Appropriate technologies should be effective, affordable, and culturally acceptable.

data science, big data, data integration
T32 Training Program for Institutions That Promote Diversity (T32 Clinical Trial Not Allowed)



Apr 27 2018

May 07 2021

The purpose of this funding opportunity announcement (FOA) is to enhance the participation of individuals from diverse backgrounds underrepresented in cardiovascular, pulmonary, hematologic and sleep disorders research across the career development continuum. The NHLBIs T32 Training Program for Institutions That Promote Diversity is a Ruth L. Kirschstein National Research Service Award Program intended to support training of predoctoral and health professional students and individuals in postdoctoral training institutions with an institutional mission focused on serving health disparity populations not well represented in scientific research, or institutions that have been identified by federal legislation as having an institutional mission focused on these populations, with the potential to develop meritorious training programs in cardiovascular, pulmonary, and hematologic diseases, and sleep disorders. The NHLBIs T32 Training Program for Institutions That Promote Diversity is designed to expand the capability for biomedical research by providing grant support to institutions that have developed successful programs that promote diversity, serve health disparity populations, and that offer doctoral degrees in the health professions or in health-related sciences. These institutions are uniquely positioned to engage minority and other health disparity populations in research, translation, and implementation of research advances that impact health outcomes, as well as provide health care for these populations. This Funding Opportunity Announcement (FOA) does not allow appointed Trainees to lead an independent clinical trial, but does allow them to obtain research experience in a clinical trial led by a mentor or co-mentor.

data science, big data, quantitative science, bioinformatics
Stimulating Access to Research in Residency (StARR) (R38)



Aug 23 2017

May 13 2020

The purpose of this program is to recruit and retain outstanding, postdoctoral-level health professionals who have demonstrated potential and interest in pursuing careers as clinician-investigators. To address the growing need for this critical component of the research workforce, this funding opportunity seeks applications from institutional programs that can provide outstanding mentored research opportunities for Resident-Investigators and foster their ability to transition to individual career development research awards. The program will support institutions to provide support for up to 2 years of research conducted by Resident-Investigators in structured programs for clinician-investigators with defined program milestones.

data science, bioinformatics
Short-Term Research Education Program to Increase Diversity in Health-Related Research (R25 Clinical Trial Not Allowed)



May 01 2018

May 07 2021

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NHLBI R25 program is to support educational activities that enhance the diversity of the biomedical, behavioral and clinical research workforce in the mission areas of importance to NHLBI.
To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Research Experiences

data science, big data, bioinformatics
Research Career Enhancement Award to Advance Therapy Development for Alzheimer's (K18)



Nov 07 2016

Jan 08 2020

This NIA Research Career Enhancement Award (K18) program invites applications from qualified researchers to acquire training and career development experiences that close expertise gaps in data science and in drug discovery. The goal of the program is to allow Alzheimer's Disease (AD) researchers to expand their expertise to become more effective in leading cross-disciplinary, translational, team-science projects in AD or AD-related dementias (ADRD). This award will also allow data scientists to redirect their expertise toward the study of AD and ADRD.

data science, computational, informatics
RESCINDED - Notice of Intent to Publish a Funding Opportunity Announcement for Rare Disease Cohorts in Heart, Lung, Blood and Sleep Disorders (UG3/UH3



Apr 13 2018


Notice Intent Publish Funding Opportunity Announcement Rare Disease Cohorts Heart, Lung, Blood Sleep Disorders UG3/UH3) Notice Number: NOT-HL-18-620 Key Dates Release Date: April 13, 2018 RESCINDED) Estimated Publication Date Funding Opportunity Announcement: 12/01/2018 First Estimated Application Due Date:02/01/2019 Earliest Estimated Award Date:10/31/2019 Earliest Estimated Start Date:12/31/2019 Related Announcements None Issued National Heart, Lung, Blood Institute NHLBI) Purpose National Heart, Lung Blood Institute intends promote new initiative establish cohorts rare heart, lung, blood, and/or sleep HLBS) diseases enables multidisciplinary teams conduct natural history mechanistic studies provide evidence base future clinical trials improved diagnostics.  studies help advance fundamental insights key molecular, genomic, clinical, environmental behavioral determinants rare HLBS diseases their outcomes leading diagnostic therapeutic strategies.   NHLBI interested applications will address questions relevant the NHLBI mission, address gaps the NHLBI?s portfolio rare disease cohorts that align the Institute ' s Strategic Vision NHLBI intends to utilize UG3/UH3 activity code, bi-phasic, milestone-driven cooperative agreement. Details the planned FOA provided below. Notice being provided allow potential applicants sufficient time develop responsive proposals.  FOA expected be published October 2018 anticipated application receipt dates February 2019 February 2020. Research Initiative Details planned initiative provide opportunities efficiently advance rare disease research using genetics deep phenotyping characterize disease to identify disease sub-types; use data science methods integrate clinical patient-reported outcomes PROs) laboratory, imaging omics data understand natural history disease;  generate data differentiate patients the same morphological phenotype different genetic mutations  severity outcomes; elucidate genotype-phenotype interactions multisystem phenotyping develop reliable valid predictive tools determine will respond which treatments when intervene; to encourage innovative methods such telemedicine reach subjects rare diseases located remote locations without access a major academic medical center. goal this initiative to encourage creative innovative research; such, applications should propose studies investigating hypotheses research questions currently addressed cohorts funding the NHLBI. RFA invite applications propose cohorts are created de novo or re-establish study populations enrolling patients previously-funded cohorts, clinical trials registries. Funding Information Estimated Total Funding 1,625,000 Total Costs) Expected Number Awards 4 Estimated Award Ceiling 500,000 Direct Costs) Primary CFDA Numbers 93.837, 93.838, 93.839, 93.840, 93.233 Anticipated Eligible Organizations Public/State Controlled Institution Higher Education Private Institution Higher Education Nonprofit 501(c)(3) IRS Status than Institution Higher Education) Nonprofit without 501(c)(3) IRS Status than Institution Higher Education) Small Business For-Profit Organization than Small Business) State Government Indian/Native American Tribal Government Federally Recognized) City township governments Indian/Native American Tribally Designated Organization Native American tribal organizations than Federally recognized tribal governments) Indian/Native American Tribal Government than Federally Recognized) Regional Organization  Applications not being solicited this time.   Inquiries Please direct inquiries to: Ellen M. Werner, PhD, MA  National Heart, Lung, Blood Institute  301-435-0065 

data science



Oct 15 2018


REQUEST PROPOSAL RFP): BIOINFORMATICS RESOURCE CENTERS INFECTIOUS DISEASES, RFP-NIAID-DMID-NIHAI201800005 Notice Number: NOT-AI-19-009 Key Dates Release Date:October 15, 2018 Related Announcements None Issued National Institute Allergy Infectious Diseases NIAID) Purpose National Institute Allergy Infectious Diseases NIAID), National Institutes Health NIH), the Department Health Human Services DHHS) supports research related the basic understanding microbiology immunology leading the development vaccines, therapeutics, medical diagnostics the prevention, treatment, diagnosis infectious immune-mediated diseases.   NIAID, Division Microbiology Infectious Diseases DMID) a requirement maintain Bioinformatics Resource Centers BRCs), have become critical resource data tools generated NIAID supported programs other publicly accessible data the infectious disease research community.   NIAID made significant investment funding basic clinical research projects are generating large, diverse complex data sets including genomics/omics data, clinical data, immune phenotyping assay data, imaging other data sets. infectious diseases immune mediated diseases communities become data-intense enterprise a priority NIAID to transform data knowledge understand pathogenesis, transmission, evolution the pathogen, pathogen-host interactions the host response infectious diseases inform development new improved diagnostics, therapeutics, vaccines. NIAID invested bioinformatics data science data generated NIAID intramural extramural communities has expanded activities data management systems, bioinformatics resource centers data repositories/knowledgebases have provided broad scientific community user friendly access open data analytical tools.   Since inception 2004, NIAID’s BRCs focused supporting providing genome sequence databases annotation microbial organisms. BRCs provided infectious disease research community publicly accessible systems store, update, integrate display genome sequence data its annotation, functional genomics other ldquo;omics” data, other associated data information a large variety human pathogens vectors human pathogens related microbial species strains. BRC systems allow users query analyze data. a result, BRCs become public repository primary resource data tools generated NIAID supported programs other publicly accessible data the infectious disease research community.   objective this solicitation to continue support the BRCs provide data-driven, production-level sustainable computational platform(s) enable sharing access usable re-usable data, portable computational tools standards support interoperability the infectious diseases research community. Through effort NIAID continue provide bioinformatics services training support large-scale, system level diverse data integration modeling, enable predictive biology pathogens host-pathogen interactions will accelerate discovery research, clinical investigation, therapeutic development infectious diseases. addition, platform infrastructure expected serve a model future NIAID systems. change the previous competition should noted: to 2) BRCs be awarded one 1) contract awarded bacterial species viral families one 1) contract awarded protozoan species, fungi invertebrate vectors human pathogens. Offerors propose one both data resources the group organisms. Funding under prior solicitation NOT required submission this solicitation.   is anticipated two 2) cost-reimbursement plus fixed-fee, level-of-effort, type contracts be awarded a one-year base period performance beginning or around September 1, 2019. Awards expected include four 4) one-year option periods. total period performance, including options, five 5) years. Government’s base level-of-effort requirement estimated 43,680 direct labor hours each contract period, equating 21 Full Time Equivalents FTEs) an FTE being defined 2,080 direct labor hours. addition the base level-of-effort, contract period shall contain option quantity up nine 9) additional FTEs.   NIAID recognizes a single organization institution not the full spectrum expertise facilities required perform activities set forth the Statement Work. Contractors need be supported a certain extent the expertise resources other organizations persons through consortia agreements, partnerships, subcontracts, and/or consultants. However, contractors shall responsible ALL work performed shall responsible project planning, initiation, implementation, management communication; evaluation, selection, management subcontractors; for deliverables specified this contract.   Any responsible Offeror submit proposal will considered the Agency. Request Proposal RFP) available electronically may accessed through FedBizOpps  notice does commit Government award contract. collect calls be accepted. facsimile transmissions be accepted   this solicitation, NIAID requires proposals be submitted via 2) methods: 1) Disc CD DVD) 2) Online via NIAID electronic Contract Proposal Submission eCPS) website. content the disc online proposals must identical. Submission proposals facsimile e-mail not acceptable.   directions using eCPS, to website and click ldquo;How Submit.” Inquiries Please direct inquiries to: Primary Contact: Brian Madgey National Institute Allergy Infectious Diseases NIAID) Telephone: 240-627-3712 Email:   Secondary Contact: Stanley Knight National Institute Allergy Infectious Diseases NIAID) Telephone: 240-669-5181 Email:

data science, computational, bioinformatics, data integration